BBIO Bridgebio Pharma, Inc.

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$7.30B

Revenue (FY)

$502.08M 2025-12-31

Net Income (FY)

$-732.94M

company in Palo Alto, United States.

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 1743881 · SEC filings · revenue ranking · home